Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker exploration for bevacizumab-containing chemotherapy in advanced ovarian cancer
jRCT1031180427Completed
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bevacizumab in ovarian cancer. Primary endpoints: Change in FDG-PET parameters and efficacy of bevacizumab and Exploratory blood biomarkers. Started Jun 2016; status: completed.
02
Drugs
bevacizumab
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on jRCT1031180427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031180427.